| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $0.47 (Miss by $-0.32) |
| EPS GAAP Actual | $0.47 (Miss by $-0.32) |
| Revenue Actual | $0.014318B |
| Revenue Surprise | Beat by $14.318M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.71 |
| EPS GAAP Estimate | $-0.71 |
| Revenue Estimate | $0.036B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2030 | 1.49 | 14.46 | 1.49 | 1.49 | 1 |
| Sep 2029 | 1.49 | 14.46 | 1.49 | 1.49 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0198 | -0.0498 | 0.014318B | 8.48% | -0.68M |
| FQ2 2025 (Jun 2025) | 0.0522 | 0.0222 | 0.0172646B | 16.26% | 2.26M |
| FQ1 2025 (Mar 2025) | 0.74 | 0.01 | 0.0364621B | 10.43% | -0.54M |
| FQ4 2024 (Dec 2024) | 0.52 | -0.01 | 0.0272895B | 10.52% | 1.29M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 0.0131043B | 4.86% | 13.1M |
| FQ2 2024 (Jun 2024) | 0.0154 | 0.0154 | 0.0144582B | 5.52% | 14.46M |
| FQ1 2024 (Mar 2024) | 0.63 | 0.63 | 0.0326594B | -16.44% | 32.66M |
| FQ4 2023 (Dec 2023) | 0.5 | 0.5 | 0.0244194B | 100% | 24.42M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.71
Consensus Revenue Estimates
0.036B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 0.05 | -- | 0.04923877 | 0.05076123 | 1 |
| FQ1 2027 (Mar 2027) | 0.76 | -- | 0.74843 | 0.77157 | 1 |
| FQ4 2026 (Dec 2026) | 0.56 | -- | 0.55147 | 0.56853 | 1 |
| FQ3 2026 (Sep 2026) | -0.01 | -98 | -0.01 | -0.01 | 1 |
| FQ2 2026 (Jun 2026) | -0.03 | 274 | -0.03 | -0.03 | 1 |
| FQ1 2026 (Mar 2026) | -0.71 | 204.23 | -0.71 | -0.71 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ1 2027 (Mar 2027) | 0.04B | -- | 0.04B | 0.04B | 1 |
| FQ4 2026 (Dec 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ3 2026 (Sep 2026) | 0.01B | -2.27 | 0.01B | 0.01B | 1 |
| FQ2 2026 (Jun 2026) | 0.02B | -7.9 | 0.02B | 0.02B | 1 |
| FQ1 2026 (Mar 2026) | 0.04B | -1.28 | 0.04B | 0.04B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.03 | -0.0198 | -0.0498 | 251.52% |
| FQ2 2025 (Jun 2025) | 0.03 | 0.0522 | 0.0222 | 42.53% |
| FQ1 2025 (Mar 2025) | 0.73 | 0.74 | 0.01 | 1.35% |
| FQ4 2024 (Dec 2024) | 0.53 | 0.52 | -0.01 | -1.92% |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.0154 | 0.0154 | 100% | |
| FQ1 2024 (Mar 2024) | 0.63 | 0.63 | 100% | |
| FQ4 2023 (Dec 2023) | 0.5 | 0.5 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.02B | $0.01B | $-0.68M | -4.76% |
| FQ2 2025 (Jun 2025) | $0.02B | $0.02B | $2.26M | 13.12% |
| FQ1 2025 (Mar 2025) | $0.04B | $0.04B | $-0.54M | -1.48% |
| FQ4 2024 (Dec 2024) | $0.03B | $0.03B | $1.29M | 4.73% |
| FQ3 2024 (Sep 2024) | $0B | $0.01B | $13.1M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.01B | $14.46M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.03B | $32.66M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.02B | $24.42M | 100% |